Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD

NCT02255227 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

104

Enrollment

OTHER

Sponsor class

Stopped low inclusion rates

Conditions

Infections, Pneumococcal
Bowel Diseases, Inflammatory

Interventions

BIOLOGICAL: Prevenar 13
BIOLOGICAL: Pneumo 23

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Collaborators

[object Object]